Breaking finance and business news, tax information, jobs and more for finance directors and senior finance professionals.

After five years as PLIVA's CFO, Mijatovic has been named to the position of senior vice president, corporate development, for the Barr Group and will now be based out of the company's US headquarters in New Jersey.

In his new role he will continue to report to Bill McKee, Barr's EVP and CFO.

Also stepping down as members of the Pliva management board are Christine Mundkur, CEO, Barr Laboratories, Inc. and Michael Bogda, president and COO, Barr Laboratories, Inc.

Both Mundkur and Bogda will continue with their global responsibilities with the Barr Group.

As previously announced, Zdravka Knezevic, former executive director of European research and development (R&D), ceased to serve as a member of the Pliva management board effective 31 March 2008.

Raffi Asadorian has been appointed as a member of the management board and as the company’s new chief financial officer.

Asadorian joined Barr in November 2007 and is senior vice president and CFO of the Pliva Group. Before joining the Barr Group he was as a partner at PricewaterhouseCoopers.

Elin Gabriel has been appointed as a member of the management board. She joined Barr in January 2008 as senior vice president, European product supply, and has over 18 years of senior supply chain and process improvement experience with broad strategic and operational experience.

Urs Brauen, who was also appointed as a member of the management board, joined PLIVA in 2001.

Most recently he has been responsible for the Western Europe region and head of the Pliva’s subsidiary AWD.pharma in Germany.

Before joining Pliva, Brauen was head of the German operations of GNR Pharma (BASF Generics).

Zeljko Covic, president of Pliva management board, and Tim Sawyer, executive vice president, global generic sales and marketing, will continue with their current positions and roles within the Pliva management board.

Pliva d.d. (LSE:PLVD), based in Zagreb, Croatia, serves as the European headquarters for Barr Pharmaceuticals, Inc., a global specialty pharmaceutical company that operates in more than 30 countries.

The Barr Group of companies is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients.

The Barr Group of companies markets more than 115 generic and 25 proprietary products in the US and more than 1,000 products globally outside of the US, in the key markets of Croatia, Germany, Poland and Russia.

Related links 

• Barr Pharmaceuticals, Inc.
• Pliva d.d.